Perspective on Thoughts and Feelings as a Predictor of Psychological Well-being in Daily Life, in a Community Sample

July 29, 2019 updated by: Kenneth G. DeMarree, State University of New York at Buffalo

Decentering in Daily Life: Underlying Mechanisms and Impact on Well-Being

This project examines the psychological construct of decentering - a mindfulness-related construct marked by an observer perspective on one's ongoing mental processes. Specifically, this project seeks to explore the extent to which decentering modulates the relationship between people's affective states and their momentary mental health and well-being, and to test the psychological processes by which decentering might exert these effects. This study includes a baseline assessment followed by a 7-day study completed from home where participants respond to brief surveys about their current experiences six times per day (i.e., an Ecological Momentary Assessment [EMA] design).

The investigators hypothesize that decentering moderates the association of extreme affect with related symptoms (i.e., elevated negative affect with depression and anxiety; elevated positive affect with mania, narcissism, and histrionic traits) and well-being, such that the association is attenuated at high levels of decentering. This will be examined using the EMA data, analyzing between-person levels (i.e., trait) as well as momentary within-person processes (i.e., concurrent and prospective states).

Further, the investigators predict that broadened attentional focus and improved self-regulation are mechanisms that contribute to the beneficial effects of decentering in daily life. This hypothesis will be examined in two ways:

  1. as individual differences, wherein greater self-regulatory abilities (e.g., higher heart rate variability) and less attentional biases towards emotional stimuli mediate the association between trait decentering and subsequent daily well-being/symptoms, and
  2. as within-person momentary levels, wherein broader attentional processes and greater self-regulation in daily life mediate the concurrent and prospective association between momentary decentering and well-being/symptoms.

Note that the study uses a multimodal assessment of each of the proposed processes. For attentional processes, a variety of parameters extracted from an emotional eye tracking paradigm will be examined. For self-regulatory abilities, assessments will include self-report, physiological (heart rate variability), and behavioral ("go / no-go" task) measures of such abilities.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

380

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Buffalo, New York, United States, 14260
        • University at Buffalo, Department of psychology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The population from which the sample will be recruited will be residents of the greater Buffalo, NY metropolitan area.

Description

Inclusion Criteria:

  • age 18-65, fluency in English

Exclusion Criteria:

  • current cognitive impairments (i.e., intellectual disability, dementia, current psychotic symptoms) that preclude giving informed consent and accurately answering study questions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Primary sample
Community sample of adults (18-65) from the greater Buffalo, NY region, oversampling people who are seeking mental health treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Momentary psychological distress
Time Frame: 6 x daily for 7 days following the baseline assessment
2 items (developed new for this study) assessing the presence and impact of idiographic symptoms identified at baseline, and 4 items assessing dysphoria adapted from the Inventory of Depression and Anxiety Symptoms (IDAS)
6 x daily for 7 days following the baseline assessment
Momentary eudaimonic well-being
Time Frame: 6 x daily for 7 days following the baseline assessment
2 items assessing eudaimonic well-being adapted from Breines et al. (2008) and Lambert et al. (2013)
6 x daily for 7 days following the baseline assessment
Momentary hedonic well-being (state positive and negative affect)
Time Frame: 6 x daily for 7 days following the baseline assessment
8 items assessing hedonic well-being (positive and negative affect), taken from the Positive and Negative Affect Schedule (PANAS).
6 x daily for 7 days following the baseline assessment
State Decentering
Time Frame: 6 x daily for 7 days following the baseline assessment
4 items assessing current decentering, adapted from Fresco et al. (2007), Gillanders et al. (2014), and Shoham et al. (2017)
6 x daily for 7 days following the baseline assessment
Trait Decentering: Experiences Questionnaire
Time Frame: Baseline session only
Experiences Questionnaire is a trait measure of decentering, which assesses the Observer Perspective aspect of decentering. From Fresco et al., (2007)
Baseline session only
Trait decentering: Valence free decentering measure
Time Frame: Baseline session only
This is an in-development measure of decentering that measures the construct of decentering without explicitly referring to negative thoughts and feelings.
Baseline session only
Trait decentering: Cognitive Fusion Questionnaire
Time Frame: Baseline session only
The Cognitive Fusion Questionnaire is a decentering measure that assesses the Reduced Struggle with Inner Experiences aspect of decentering. From Gillanders et al., (2014).
Baseline session only
Trait decentering: Toronto Mindfulness Scale-Decentering Subscale
Time Frame: Baseline session only
The Toronto Mindfulness Scale-Decentering subscale is a decentering measure that assesses the Observer Perspective aspect of decentering. From Davis, Lau, & Cairns (2009).
Baseline session only

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported momentary self-regulation
Time Frame: 6 x daily for 7 days following the baseline assessment
3 questions assessing current perceived willpower & mental exhaustion, adapted from Davisson (2013) and Milyavskaya & Inzlicht (2017).
6 x daily for 7 days following the baseline assessment
Self-reported momentary attentional focus
Time Frame: 6 x daily for 7 days following the baseline assessment
4 attentional emotion regulation items (distraction, positive rumination, negative rumination, and reappraisal) adapted from Brans et al. (2013), Feldman et al. (2008), and Nolen-Hoeksema & Morrow (1991)
6 x daily for 7 days following the baseline assessment
Baseline self-regulation: Go/no-go task
Time Frame: Baseline session only
Go/no-go task asks people to respond to a large number of "go" trials (80%) and a smaller number of "no go" trials. The ability to inhibit the dominant "go" response is seen as an operative measure of self-regulatory abilities, consequently the number of "no go" signals responded to is one measure of self-regulatory abilities.
Baseline session only
Baseline self-regulation: Resting heart rate variability
Time Frame: Baseline session only
Assessed with a Polar V800 athletic watch during a 5-minute vanilla baseline and a 5-minute paced breathing task.
Baseline session only
Baseline self-regulation: Self-Control Scale (short form)
Time Frame: Baseline session only
A self-report measure of people's perceived self-control abilities and outcomes, developed by Tangney, Baumeister, & Boone (2004).
Baseline session only
Baseline attentional breadth: Emotional eye-tracking paradigm
Time Frame: Baseline session only
Participants will view a series of emotionally expressive versus neutral faces, and the fixation time and number of fixations towards emotionally evocative (angry, sad, happy) faces will serve as indicators of attentional bias
Baseline session only
Baseline attentional breadth: Thought Control Questionnaire
Time Frame: Baseline session only
Self-report measure corresponding to various emotion regulation strategies (distraction and reappriasal)
Baseline session only
Baseline attentional breadth: Responses to Positive Affect Scale
Time Frame: Baseline session only
Self-report measure corresponding to various emotion regulation strategies (positive rumination)
Baseline session only
Baseline attentional breadth: Ruminative Responses Scale
Time Frame: Baseline session only
Self-report measure corresponding to various emotion regulation strategies (negative rumination)
Baseline session only

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kristin Gainey, Ph.D., University at Buffalo
  • Principal Investigator: Kenneth G DeMarree, Ph.D., University at Buffalo

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 6, 2017

Primary Completion (Actual)

December 7, 2018

Study Completion (Actual)

December 17, 2018

Study Registration Dates

First Submitted

October 25, 2017

First Submitted That Met QC Criteria

November 7, 2017

First Posted (Actual)

November 8, 2017

Study Record Updates

Last Update Posted (Actual)

July 30, 2019

Last Update Submitted That Met QC Criteria

July 29, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 1R21AT009470-01 (U.S. NIH Grant/Contract)
  • R21AT009470 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD that underlie results in a publication will be shared.

IPD Sharing Time Frame

Materials will be made available 6 months after publication of the primary outcomes.

IPD Sharing Access Criteria

Data and study materials relevant to any publication will be posted within 6 months of publication on the open science framework, which will be accessible by any interested party.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health

3
Subscribe